This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sedman, S A
Right arrow Articles by Schiller, J T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sedman, S A
Right arrow Articles by Schiller, J T

 Previous Article  |  Next Article 

J Virol. 1991 September; 65(9): 4860-4866

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.

S A Sedman, M S Barbosa, W C Vass, N L Hubbert, J A Haas, D R Lowy and J T Schiller

Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The wild-type E6 and E7 genes of human papillomavirus type 16 (HPV16) can cooperate to immortalize normal human keratinocytes in culture. The E6 open reading frame of HPV16 and other HPV types highly associated with cervical cancer has the potential of encoding both full-length E6 and two truncated E6* proteins, the latter being generated via splicing within the E6 open reading frame portion of the E6-E7 polycistronic transcript. Those types, such as HPV6, that are infrequently associated with cervical carcinoma lack the splice site and encode only a full-length E6. We have now found that, in addition to cooperating with E7 to immortalize keratinocytes, HPV16 E6 can induce anchorage-independent growth in NIH 3T3 cells and trans-activate the adenovirus E2 promoter. HPV6 E6 was also able to trans-activate the adenovirus E2 promoter, although it was inactive in both cell transformation assays. An HPV16 splice site mutant which expressed only the full-length HPV16 E6 was active in all three assays, indicating that the E6* proteins are not required for these activities. The plasmid which encodes the E6* proteins was inactive and did not potentiate the activity of the HPV16 splice site mutant. The mutation that prevented splicing in E6-E7 mRNA severely reduced the level of E7 protein and increased E6 protein. Taken together, the results suggest that the primary function of the splice within E6 is to facilitate the translation of E7 and reduce translation of full-length E6, rather than to generate biologically active E6* proteins.

J Virol. 1991 September; 65(9): 4860-4866




This article has been cited by other articles:

  • Filippova, M., Johnson, M. M., Bautista, M., Filippov, V., Fodor, N., Tungteakkhun, S. S., Williams, K., Duerksen-Hughes, P. J. (2007). The Large and Small Isoforms of Human Papillomavirus Type 16 E6 Bind to and Differentially Affect Procaspase 8 Stability and Activity. J. Virol. 81: 4116-4129 [Abstract] [Full Text]  
  • Storrs, C. H., Silverstein, S. J. (2007). PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6. J. Virol. 81: 4080-4090 [Abstract] [Full Text]  
  • Rehtanz, M., Ghim, S.-j., Rector, A., Van Ranst, M., Fair, P. A., Bossart, G. D., Jenson, A. B. (2006). Isolation and characterization of the first American bottlenose dolphin papillomavirus: Tursiops truncatus papillomavirus type 2. J. Gen. Virol. 87: 3559-3565 [Abstract] [Full Text]  
  • Tang, S., Tao, M., McCoy, J. P. Jr., Zheng, Z.-M. (2006). The E7 Oncoprotein Is Translated from Spliced E6*I Transcripts in High-Risk Human Papillomavirus Type 16- or Type 18-Positive Cervical Cancer Cell Lines via Translation Reinitiation. J. Virol. 80: 4249-4263 [Abstract] [Full Text]  
  • Nakahara, T., Peh, W. L., Doorbar, J., Lee, D., Lambert, P. F. (2005). Human Papillomavirus Type 16 E1{wedge}E4 Contributes to Multiple Facets of the Papillomavirus Life Cycle. J. Virol. 79: 13150-13165 [Abstract] [Full Text]  
  • Filippova, M., Parkhurst, L., Duerksen-Hughes, P. J. (2004). The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis. J. Biol. Chem. 279: 25729-25744 [Abstract] [Full Text]  
  • Tao, M., Kruhlak, M., Xia, S., Androphy, E., Zheng, Z.-M. (2003). Signals That Dictate Nuclear Localization of Human Papillomavirus Type 16 Oncoprotein E6 in Living Cells. J. Virol. 77: 13232-13247 [Abstract] [Full Text]  
  • Stacey, S. N., Jordan, D., Williamson, A. J. K., Brown, M., Coote, J. H., Arrand, J. R. (2000). Leaky Scanning Is the Predominant Mechanism for Translation of Human Papillomavirus Type 16 E7 Oncoprotein from E6/E7 Bicistronic mRNA. J. Virol. 74: 7284-7297 [Abstract] [Full Text]  
  • Graham, D A, Herrington, C S (2000). HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities. Mol. Pathol. 53: 201-206 [Abstract] [Full Text]  
  • Kao, W. H., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M., Howley, P. M. (2000). Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase. J. Virol. 74: 6408-6417 [Abstract] [Full Text]  
  • Liu, Y., Tergaonkar, V., Krishna, S., Androphy, E. J. (1999). Human Papillomavirus Type 16 E6-enhanced Susceptibility of L929 Cells to Tumor Necrosis Factor alpha Correlates with Increased Accumulation of Reactive Oxygen Species. J. Biol. Chem. 274: 24819-24827 [Abstract] [Full Text]  
  • Beerheide, W., Bernard, H.-U., Tan, Y.-J., Ganesan, A., Rice, W. G., Ting, A. E. (1999). Potential Drugs Against Cervical Cancer: Zinc-Ejecting Inhibitors of the Human Papillomavirus Type 16 E6 Oncoprotein. JNCI J Natl Cancer Inst 91: 1211-1220 [Abstract] [Full Text]  
  • Ronco, L. V., Karpova, A. Y., Vidal, M., Howley, P. M. (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12: 2061-2072 [Abstract] [Full Text]  
  • Chen, J. J., Hong, Y., Rustamzadeh, E., Baleja, J. D., Androphy, E. J. (1998). Identification of an alpha  Helical Motif Sufficient for Association with Papillomavirus E6. J. Biol. Chem. 273: 13537-13544 [Abstract] [Full Text]  
  • Berezutskaya, E., Bagchi, S. (1997). The Human Papillomavirus E7 Oncoprotein Functionally Interacts with the S4 Subunit of the 26 S Proteasome. J. Biol. Chem. 272: 30135-30140 [Abstract] [Full Text]  
  • Cheng, S, Schmidt-Grimminger, D C, Murant, T, Broker, T R, Chow, L T (1995). Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.. Genes Dev. 9: 2335-2349 [Abstract]  
  • Pan, H, Griep, A E (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.. Genes Dev. 8: 1285-1299 [Abstract]  
  • Moles, J., Schiller, J., Tesniere, A, Leigh, I., Guilhou, J., Basset-Seguin, N (1994). Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J. Cell Sci. 107: 435-441 [Abstract]  
  • Liu, Y., Hong, Y., Androphy, E. J., Chen, J. J. (2000). Rb-independent Induction of Apoptosis by Bovine Papillomavirus Type 1 E7 in Response to Tumor Necrosis Factor alpha. J. Biol. Chem. 275: 30894-30900 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»